115-2-醫學三-33風濕免疫科
關於inflammatory myositis的myositis specific antibodies與臨床表現，下列敘述何者最不適當？
Aanti–MDA5 antibodies：amyopathic dermatomyositis with digital ulcers
Banti–NXP–2 antibodies：higher risk of cancer
Canti–Mi–2 antibodies：a favorable response to treatment
Danti–TIF1–γ antibodies：lower risk of cancer
核心考點
肌炎特異抗體各有固定的臨床型態。Anti-TIF1-γ（與 anti-NXP-2）與癌症風險升高相關，所以說 TIF1-γ「風險較低」是錯的。